Jesús María
Hernández Rivas
Catedrático de Universidad
![Foto de Jesús María](/img/uploaded/22eccb650f0a1f4a59fe4629ca87e13e.jpg)
![Foto de Hospital Universitario Príncipe de Asturias](/img/noimage_org.png)
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (5)
2024
2016
-
Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method
Annals of Hematology, Vol. 95, Núm. 5, pp. 719-732
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
2012
-
Response to imatinib mesylate in patients with hypereosinophilic syndrome
International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326